Balancing Innovation: India’s Views for Pharmaceuticals in the Efta Trade Deal
IIPRD
APRIL 2, 2024
The inclusion of TRIPS-plus provisions within trade agreements presents a potential challenge to global access to essential medicines. This price inflation can significantly hinder affordability and ultimately restrict access to life-saving medications. [vi] xiii] Ensuring access to affordable medications is a key priority for India.
Let's personalize your content